PUBLIC COMPANY
save$IOVAIOVANCE BIOTHERAPEUTICS, INC.
$IOVA8.9900+12.52%San Carlos, CA, USupdated 8m ago
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
community read0 votes
pipeline
5
marketed
1
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
3Phase 21Phase 31Marketed
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
- phase2A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
- —Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
- phase2Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- phase1Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
- phase3Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- phase2Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
- phase1Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 9, 26grantGRAF FINCKENSTEIN FRIEDRICH · Chief Medical Officer58,750 sh
- Mar 9, 26grantKirby Daniel Gordon · Chief Commercial Officer132,200 sh
- Mar 9, 26grantBILINSKY IGOR · Chief Operating Officer117,500 sh
- Mar 9, 26grantRoche Corleen M. · Chief Financial Officer132,200 sh
- Mar 9, 26grantVogt Frederick G · Interim CEO & General Counsel235,000 sh
- Mar 9, 26grantPuri Raj K. · Chief Regulatory Officer117,500 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
Where IOVANCE BIOTHERAPEUTICS, INC. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaOncology 38
News
no news has mentioned this company yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that